+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis



A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis



Oncotarget 8(4): 6513-6525



Differently expressed microRNAs (miRNAs) in the plasma of lung adenocarcinoma (LA) patients might serve as biomarkers for LA detection. MiRNA expression profiling was performed using Exiqon panels followed by the verification (30 LA VS. 10 healthy controls (HCs)) with quantitative reverse transcription polymerase chain reaction (qRT-PCR) in the screening phase. Identified miRNAs were confirmed through training (42 LA VS. 32 HCs) and testing stages (66 LA VS. 62 HCs) by using qRT-PCR based absolute quantification methods. A total of six up-regulated plasma miRNAs (miR-19b-3p, miR-21-5p, miR-221-3p, miR-409-3p, miR-425-5p and miR-584-5p) were identified. The six-miRNA panel could discriminate LA patients from HCs with areas under the receiver operating characteristic curve of 0.72, 0.74 and 0.84 for the training, testing and the external validation stage (33 LA VS. 30 HCs), respectively. All the miRNAs identified except miR-584-5p were significantly up-regulated in LA tissues. MiR-19-3p, miR-21-5p, miR-409-3p and miR-425-5p showed high expression in arterial plasma with borderline significance. Additionally, miR-19-3p, miR-21-5p and miR-221-3p were significantly up-regulated in exosomes extracted from LA peripheral plasma samples. In conclusion, we identified a six-miRNA panel in peripheral plasma which might give assistance to the detection of LA at least for Asian population to a certain extent.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059405296

Download citation: RISBibTeXText

PMID: 28036284


Related references

A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma. Oncotarget 8(21): 34468-34480, 2017

Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. Plos one 10(3): E0121499, 2015

Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules. Oncotargets and Therapy 10: 5915-5926, 2017

MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. Journal of Translational Medicine 9: 159, 2011

A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Gene 687: 246-254, 2019

Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis. Biomarkers in Medicine 11(5): 431-441, 2017

Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasma. Bmc Gastroenterology 10: 115, 2010

Diagnostic Value of MiR-125b as a Potential Biomarker for Stage I Lung Adenocarcinoma. Current Molecular Medicine 19(3): 216-227, 2019

A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Biochemical and Biophysical Research Communications 493(3): 1322-1328, 2017

A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Cancer Prevention Research 4(1): 137-149, 2011

Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. World Journal of Gastrointestinal Oncology 6(1): 22-33, 2014

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. International Journal of Cancer 127(12): 2870-2878, 2010

Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma. Oncology Reports 33(6): 2915-2923, 2015

Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer. Oncology Reports 39(3): 1338-1346, 2018

Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens 78(2): 120-128, 2011